BOLT
Bolt Biotherapeutics, Inc. Common Stock
stockNASDAQ
Market OpenOct 23, 2026 2:22:19 PM EDT
6.83USD+63.007%(+2.64)12,007,834
BOLT Financials
In Q2 FY 2026 (ended ), Bolt Biotherapeutics, Inc. Common Stock (BOLT) reported revenue of $5K, net income of −$7.72M, operating cash flow of −$6.54M, and assets of $40.34M.
Loading financial statements…